Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Nov 17;3:54. doi: 10.1186/s40425-015-0097-6

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Li et al. 2015

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 2 — Granulocytic MDSC (LIN⁻CD11b⁺CD15⁺) in the peripheral blood of HNSCC patients decreased after cetuximab treatment. Levels of granulocytic MDSC (LIN⁻CD11b⁺CD15⁺) in the peripheral blood of healthy donors versus HNSCC patients and patients pre- and post-cetuximab treatment were analyzed by flow cytometry. a Representative figures showing frequency of CD15⁺ cells in LIN⁻CD11b⁺ mononuclear cells in peripheral blood from healthy donors and HNSCC patients. b Representative figures showing percentage of CD15⁺ cells in circulating LIN⁻CD11b⁺ cells in HNSCC patients before and after cetuximab treatment. c Summary data of frequency of LIN⁻CD11b⁺CD15⁺ cells in live PBMC pre- and post-cetuximab treatment in the total 24 HNSCC patients (left panel, **p < 0.01) and in responders (n = 8, **p < 0.01) and non-responders (n = 16) of UPCI 08–013 trial (right panel). Statistical significance was determined by Wilcoxon matched-pairs signed rank tests. **p < 0.01. p > 0.05 was considered to be not significant (n.s.)